Integrated Proteomics and Single-Cell Mass Cytometry Analysis Dissects the Immune Landscape of Ankylosing Spondylitis

Hao Wang1,2, Fengting Luo3, Xianfeng Shao4

  • 1Department of Clinical Laboratory, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou 450008, China.

Insights

Integrating mass spectrometry proteomics with mass cytometry reveals immune cell changes in ankylosing spondylitis (AS). This approach identified key protein alterations and cellular interactions, offering insights into AS pathogenesis and potential therapeutic targets.

Area of Science:

  • Immunology
  • Proteomics
  • Single-cell analysis

Background:

  • Mass cytometry is a key single-cell technology for immune cell analysis but is limited to a few dozen proteins.
  • Understanding immune cell heterogeneity in diseases like ankylosing spondylitis (AS) requires deeper molecular insights.
  • Current methods necessitate prior knowledge of specific protein markers for analysis.

Purpose of the Study:

  • To integrate mass spectrometry-based proteomics with single-cell mass cytometry for a comprehensive immune system analysis.
  • To investigate the immune landscape of ankylosing spondylitis (AS) by identifying proteomic and cellular alterations.
  • To uncover potential therapeutic targets and cellular phenotypes for AS treatment.

Main Methods:

  • Quantitative proteomics was used to analyze proteome alterations in peripheral blood mononuclear cells (PBMCs) from AS patients.
  • Mass cytometry was employed to decipher the immunome, focusing on differentially expressed signaling molecules identified by proteomics.
  • Correlation analysis was performed to understand cellular interactions within immune cell subclusters.

Main Results:

  • A wide spectrum of dysregulated proteins was identified in AS, including upregulated glycolytic enzymes and downregulated lipid transporters.
  • Chemokine signaling molecules involved in inflammation and leukocyte migration were found to be dysregulated.
  • Single-cell analysis revealed upregulated chemokine signaling regulators in innate and adaptive immune cell subclusters in AS, alongside interplay between monocyte, CD4+ T cell, and CD8+ T cell subclusters.

Conclusions:

  • The integration of mass spectrometry proteomics and single-cell mass cytometry is a powerful strategy for in-depth immune system understanding.
  • This combined approach revealed clinically relevant information about immune cell phenotypes and protein alterations in AS.
  • The findings provide a foundation for developing novel therapeutic strategies targeting identified pathways and cell populations in AS.

Related Concept Videos